The Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: Evidence from Randomized Controlled Trials. Lin F, Yao Q, Yu B, Deng Z, et al. Int J Clin Pract 2023;2023:6638089.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin F, Yao Q, Yu B, Deng Z, et al. The Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: Evidence from Randomized Controlled Trials. Int J Clin Pract 2023;2023:6638089.
PMID: 37588100